A
Amarin Corporation plc (AMRN)
NCM – Real Time Price. Currency in USD
14.95
-0.07 (-0.47%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
14.95
-0.07 (-0.47%)
At close: May 12, 2026, 4:00 PM EDT
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
| Name | Position |
|---|---|
| Dr. David Keenan Ph.D. | Executive VP & Chief Operating Officer |
| Dr. Steven B. Ketchum Ph.D. | Executive VP, President of Research & Development and Chief Scientific Officer |
| Mr. Aaron D. Berg | CEO, President & Director |
| Mr. Eric Boothe | Senior Vice President of Corporate Development |
| Mr. Jonathan N. Provoost | Executive VP, Chief Legal & Compliance Officer and Secretary |
| Mr. Peter L. Fishman | Senior VP & CFO |
| Date | Type | Document |
|---|---|---|
| 2026-04-29 | 8-K | amrn-20260429.htm |
| 2026-04-29 | 10-Q | amrn-20260331.htm |
| 2026-04-10 | DEF 14A | amrn-20260410.htm |
| 2026-03-30 | PRE 14A | amrn-20260330.htm |
| 2026-03-27 | 8-K | amrn-20260325.htm |
| 2026-03-02 | 10-K | amrn-20251231.htm |
| 2026-02-25 | 8-K | amrn-20260225.htm |
| 2026-01-08 | 8-K | amrn-20260108.htm |
| 2025-10-29 | 10-Q | amrn-20250930.htm |
| 2025-10-22 | 8-K | amrn-20251017.htm |